Read More Pharma Industry News Pfizer’s inotuzumab ozogamicin gains FDA priority review in acute lymphoblastic leukemia Pfizer Inc. has received a priority review designation from the U.S. Food and Drug Administration (FDA) for its… bypharmanewsdailyFebruary 23, 2017
